The Global Fund’s 7th replenishment raised US$15.7 billion in pledges to be used for the 2023-2025 funding cycle. Implementing countries will soon receive their allocation letters indicating how much they can receive for the next cycle with a proposed split by component/disease. It is advisable to look at the Allocation Methododology to “determine the funding…
The 48th Global Fund Board Meeting occurred in Geneva from 15th-17th November 2022. The two African constituencies (East and Southern Africa and West and Central Africa) led by their Global Fund board and alternate board members, and 21 delegates represented the continent. Decision Approved The following six key decisions were approved at the board meeting:…
As the 48th Global Fund Board meeting just ended with a renewal of the leadership of the Implementers Group (ImG), we would like to take the opportunity to dissect this particular platform that has had an African representative in its leadership. Robyn Montgomery from Developed Country NGOs constituency was chair, and Dr Gerald Gwinji from East…
What is conflict of interest? A conflict of interest occurs when people in position of power can make themselves, their family members, their close allies, their institutions, etc. benefit privately from their official decisions, actions, or omission. In other words, when people are judge and party. The Global Fund has a policy on Conflict of…
The African Constituency Bureau in collaboration with the Global Fund Secretariat, WHO AFRO Regional Director’s Office, the Ministry of Health of the Democratic Republic of Congo and Togo, held successful Global Fund 7th replenishment advocacy discussions on the margins of the 72nd WHO AFRO regional committee meeting in Lomé, Togo on 26th August 2022. The…
The Annual Consultative Meeting of the Global Fund’s African Constituency Bureau is the opportunity to bring together the 46 countries of the African constituencies to exchange views on the policy issues which are the topics for discussion on the agenda for the Global Fund Board Meeting. This year is special. The African Constituency Bureau is celebrating…
This resistance, already reported in some countries of the continent, simply translates into longer recovery time. But it is feared that in the long term, it might cause the treatment to become totally ineffective. Malaria experts are concerned about the increasing resistance of the malaria pathogen Plasmodium falciparum to artemisinin-based combination therapies (ACTs), the only…
The Global Fund 7th replenishment investment case was unveiled during the Global Fund preparatory meeting, that was hosted virtually by a coalition of five countries namely; the Democratic Republic of the Congo, Kenya, Rwanda, Senegal and South Africa on February 23, 2022. The Global Fund’s target for the Seventh Replenishment aims at raising at least…
A new HIV variant, more virulent and contagious, has emerged. This variant, known as VB, causes an early onset of opportunistic diseases, however It could not spread owing to the effectiveness of prevention and ARV treatment programs implemented in the Netherlands where it is circulating. A new variant of the human immunodeficiency virus (HIV) that…
Globally, new HIV infections declined by 44% between 2000 and 2021, missing the global target for a 75% reduction in new infections by 2020. The Global Fund Technical Evaluation Reference Group (TERG) published a thematic review on primary HIV prevention, in May 2021 to weigh in on discussions for the 2023-28 Global Fund Strategy. This…